{"name":"Intravacc B.V.","slug":"intravacc-b-v","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Avacc 10","genericName":"Avacc 10","slug":"avacc-10","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Avacc 10","genericName":"Avacc 10","slug":"avacc-10","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQQkY5Z2FiWHozejVVdF9qUDVSU0QyTWtqVFFoVDN2NGhwcW5EbmdUMHVxVWx0Y1QtNm94anVXZ2gtOWhhdWhOVTN6OHR2OE5ZMGpCbTZFd3FhMzJFWUNJRHVXTnlRSHYzMWlYVVRfYmJpNXNiQ1NmcnpUOC1fRGRmNVdBSnNTVzlITjZDN25hekxQVVlWdXg1N0dTN2RFY2UzdDJVRkJjVXFDczU2TUR0Rk1lOTZjVG1RTnNkbm43aTJWVlRiVHJNZzJoV1ZyRElTdmtFdWNJQndFZThIb1p3VkRoa2VKVjZ4ekJOVVFGWTc3LURGYjgxaF9B?oc=5","date":"2023-09-14","type":"pipeline","source":"globenewswire.com","summary":"Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention - globenewswire.com","headline":"Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPbWxLV0JJdTVLb0h2eHlVM1FyLU11RUtSRVRTRlRoNDd4aW5NVnQzUTJwa3l6QVVyM3hZTVBGSk9OQVg1OHVnVERqX1VlM3hGbUh1ZVhJM1R2enUtbTdRWTFHUnZwUTV3Tmo4Z0xqV3AzdV8ydHFXM1BqM0FxbC1ZYUFROA?oc=5","date":"2023-05-09","type":"pipeline","source":"Contract Pharma","summary":"Dutch State Sells Intravacc B.V. - Contract Pharma","headline":"Dutch State Sells Intravacc B.V.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOWlc2cDRadTJuMnI5amxRM09qTEJQWm1JbzlMTE5IU3p3bmxQVjdMX1liVXE0a1hVREM2V25ucE5lUVBjUEZQWURUZ2k2VWcyaFBzZ1RBZDF4N09YSUZ3TGdOMXVhNHk2dnlVWF9PMU00VHlQTzAwN1QxQ3V5U05ES1I4Q3dPcjdhc3JkaHNGd1JBaGVMcjNQb0s2SDhFbTc0UUE1YlhiM1NkekFKZjFaSm5GdXM5LXFObUE?oc=5","date":"2023-05-03","type":"pipeline","source":"PR Newswire","summary":"Dutch State Announces the Sale of Intravacc B.V. (The Netherlands) - PR Newswire","headline":"Dutch State Announces the Sale of Intravacc B.V. (The Netherlands)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPYldzOHFDZlFfYjFKbGRFRVI2enFHNVBLX3Y1cXBqR3lLYndneE91bWJMQVlLM1RSS0hFcTVteVB6ZDhCbUNxdHlxTDFWbUlGNGFUVm1ubG5XU05zQzZLckw0dkRwNGkwcWtnLW1iUlc5UUZFSno2N0diUEJLRmtpajhMZHFhenZLa3FUYXNOR3I5QzVDSlZpNXNUbWhqUQ?oc=5","date":"2023-05-03","type":"pipeline","source":"European Biotechnology Magazine","summary":"Dutch State to sell share capital of Intravacc BV - European Biotechnology Magazine","headline":"Dutch State to sell share capital of Intravacc BV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQY3podkdkM2daY0pIVzRfcjRLR3BadUM3eHFPV2hESFpsMUdPM1l2NzczbzJQMGJyM0s0dE5DX04wdkRsMHBCQVZDbjNIV2NtWHJGNDJkUS1KZHp3d081N0JMMWZrUEJscTliX3FxOW04ZVVxc3psRVEwM0VtNUg1NFAtbjFpQVFKbTdJUHdNTU9fQ21NTmNKSmJnOS1CSkxvUkFQcQ?oc=5","date":"2022-10-05","type":"deal","source":"cepi.net","summary":"CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccine - cepi.net","headline":"CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccine","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}